BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,284,822 | -17.2% | 1,332,401 | -0.0% | 0.01% | -17.6% |
| Q2 2023 | $60,706,064 | +17.2% | 1,332,443 | +4.4% | 0.02% | +13.3% |
| Q1 2023 | $51,786,928 | +3.9% | 1,276,797 | +30.5% | 0.02% | 0.0% |
| Q4 2022 | $49,860,841 | +20.0% | 978,239 | +26.9% | 0.02% | +7.1% |
| Q3 2022 | $41,535,000 | -29.1% | 771,138 | -15.5% | 0.01% | -22.2% |
| Q2 2022 | $58,582,000 | -23.5% | 912,053 | -7.7% | 0.02% | -10.0% |
| Q1 2022 | $76,614,000 | -9.0% | 988,058 | +0.8% | 0.02% | -4.8% |
| Q4 2021 | $84,150,000 | -32.2% | 980,316 | -36.5% | 0.02% | -22.2% |
| Q3 2021 | $124,082,000 | +3.2% | 1,542,733 | +3.3% | 0.03% | +3.8% |
| Q2 2021 | $120,217,000 | +52.3% | 1,493,375 | +59.6% | 0.03% | +52.9% |
| Q1 2021 | $78,941,000 | -14.1% | 935,971 | -24.1% | 0.02% | -22.7% |
| Q4 2020 | $91,847,000 | -15.7% | 1,232,761 | -13.3% | 0.02% | -26.7% |
| Q3 2020 | $108,948,000 | -54.0% | 1,421,895 | -49.5% | 0.03% | -56.5% |
| Q2 2020 | $236,651,000 | +35.7% | 2,815,388 | +27.2% | 0.07% | +15.0% |
| Q1 2020 | $174,388,000 | -1.2% | 2,212,542 | +4.0% | 0.06% | +25.0% |
| Q4 2019 | $176,422,000 | -17.2% | 2,126,474 | -13.5% | 0.05% | -20.0% |
| Q3 2019 | $213,172,000 | +2.7% | 2,456,980 | -3.8% | 0.06% | +1.7% |
| Q2 2019 | $207,496,000 | -15.6% | 2,553,252 | -15.5% | 0.06% | -19.2% |
| Q1 2019 | $245,768,000 | +7.1% | 3,022,588 | -13.8% | 0.07% | -3.9% |
| Q4 2018 | $229,513,000 | -26.8% | 3,504,642 | -13.8% | 0.08% | -14.6% |
| Q3 2018 | $313,396,000 | -25.9% | 4,065,336 | -29.0% | 0.09% | -28.8% |
| Q2 2018 | $422,818,000 | +12.2% | 5,726,130 | -1.1% | 0.12% | +12.6% |
| Q1 2018 | $376,692,000 | -13.5% | 5,791,700 | -14.4% | 0.11% | -11.9% |
| Q4 2017 | $435,674,000 | +22.6% | 6,765,184 | +17.7% | 0.13% | +14.5% |
| Q3 2017 | $355,269,000 | +5.4% | 5,747,905 | +3.3% | 0.11% | +1.9% |
| Q2 2017 | $336,943,000 | +9.7% | 5,565,619 | -6.7% | 0.11% | +8.0% |
| Q1 2017 | $307,083,000 | +22.8% | 5,967,637 | +5.8% | 0.10% | +13.6% |
| Q4 2016 | $250,157,000 | +90.3% | 5,641,785 | +98.1% | 0.09% | +83.3% |
| Q3 2016 | $131,442,000 | +3.9% | 2,847,724 | +1.8% | 0.05% | -2.0% |
| Q2 2016 | $126,491,000 | +20.6% | 2,797,265 | +9.6% | 0.05% | +16.7% |
| Q1 2016 | $104,890,000 | +21.6% | 2,553,315 | +12.9% | 0.04% | +23.5% |
| Q4 2015 | $86,247,000 | +30.8% | 2,260,730 | +12.6% | 0.03% | +21.4% |
| Q3 2015 | $65,928,000 | -87.8% | 2,006,936 | -74.1% | 0.03% | -86.6% |
| Q2 2015 | $541,674,000 | -66.3% | 7,755,910 | -66.9% | 0.21% | -33.2% |
| Q1 2015 | $1,605,320,000 | +91.5% | 23,435,616 | +104.8% | 0.31% | -4.9% |
| Q4 2014 | $838,465,000 | +4.5% | 11,440,383 | +2.3% | 0.33% | -2.1% |
| Q3 2014 | $802,367,000 | -5.4% | 11,179,749 | -4.7% | 0.34% | -4.0% |
| Q2 2014 | $848,587,000 | -0.2% | 11,736,488 | +1.6% | 0.35% | -3.0% |
| Q1 2014 | $850,020,000 | +9.8% | 11,552,699 | +3.8% | 0.36% | +7.4% |
| Q4 2013 | $773,836,000 | +11.3% | 11,126,320 | +5.1% | 0.34% | +1.5% |
| Q3 2013 | $695,197,000 | +17.7% | 10,582,992 | +24.1% | 0.33% | +8.2% |
| Q2 2013 | $590,735,000 | – | 8,527,999 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |